文献速递妇科产科

卵巢癌诊断前胃肠道症状与治疗分配及诊断延迟的关系

Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delay.
PubMed 文献 · Gynecol Oncol · 2021-04-01

这项回顾性数据库研究纳入6286例新诊断卵巢癌患者,分析诊断前一年内胃肠道疾病索赔与治疗分配的关系。结果显示22%患者诊断前有至少一种胃肠道疾病诊断,有胃肠道诊断者更可能接受新辅助化疗而非初次减瘤手术(OR 1.37,P<0.0001;校正后OR 1.24,P=0.001),提示胃肠道症状可能反映更晚期疾病。

要点

  • 卵巢癌诊断前一年内22%患者有胃肠道疾病诊断记录。
  • 有胃肠道诊断者接受新辅助化疗的 odds 更高(校正后OR 1.24,P=0.001)。
  • 胃肠道主诉女性应考虑卵巢癌鉴别诊断,可能影响治疗分配。

核心结论

  • 卵巢癌诊断前有胃肠道疾病索赔者更可能接受新辅助化疗,提示更晚期疾病和更差预后。

研究设计与样本

  • 回顾性研究,使用IBM MarketScan美国商业保险和Medicare数据库,纳入2015年1月至2019年1月新诊断卵巢癌患者6286例。

主要发现

  • 6286例患者中22%在卵巢癌诊断前有至少一种胃肠道疾病诊断。
  • 有胃肠道诊断的患者中39%在卵巢癌诊断前6至12个月被诊断胃肠道疾病,61%在6个月内被诊断。
  • 有胃肠道诊断的女性更可能接受新辅助化疗而非初次减瘤手术(OR 1.37,P<0.0001)。
  • 控制年龄、地区、保险计划类型和索引年份后,关联仍显著(OR 1.24,P=0.001)。

临床怎么用

  • 对以胃肠道症状就诊的女性,应将卵巢癌纳入鉴别诊断,以避免诊断延迟并影响治疗分配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether gastrointestinal (GI) disorder insurance claims in the year preceding a diagnosis of ovarian cancer (OC) lead to differing treatment allocations. The hypothesis is that GI disorders may be indicative of advanced OC. METHODS: This retrospective study identified patients with newly diagnosed OC from January 2015 to January 2019 in the IBM® MarketScan® US commercial insurance and Medicare databases. Analysis was limited to patients with primary or interval debulking surgery or chemotherapy, with or without GI claims in the year prior to diagnosis, with commercial or Medicare coverage for ≥12 months prior and ≥1 month after the index date. Patients were compared in terms of the odds of treatment with neoadjuvant chemotherapy (NCT) or primary debulking surgery (PDS) (logistic regression analysis). Median treatment-free interval in the subset of patients with antineoplastic treatment was compared (Kaplan-Meier analysis). RESULTS: Of the 6286 patients, 22% had a diagnosis of ≥1 GI disorder before their OC diagnosis. Of these patients, 39% were diagnosed with a GI disorder between 6 and 12 months before OC diagnosis and 61% were diagnosed <6 months prior. Women with a GI diagnosis were more likely to undergo NCT than PDS (odds ratio [OR], 1.37; P < 0.0001); this remained significant even when controlling for age, region, insurance plan type, and index year (OR, 1.24; P = 0.001). CONCLUSIONS: In this database, ≈25% of women with OC had a GI claim within the past year and were more likely treated with NCT, an indicator of more advanced disease with a worse prognosis. This suggests that OC should be considered in the differential diagnosis among women with GI complaints, which could alter treatment allocation.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Chase DM, Neighbors J, Perhanidis J, et al. Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delay. Gynecol Oncol. 2021. PMID: 33814195. doi:10.1016/j.ygyno.2021.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。